Literature DB >> 7735282

The defense reaction: a common denominator of coronary risk and blood pressure in neurogenic hypertension?

S Julius1.   

Abstract

In addition to high blood pressure, patients with hypertension often have insulin resistance, dyslipidemia and increased sympathetic tone. An increased sympathetic tone can negatively affect glucose utilization through three distinct mechanisms; a direct beta-adrenoreceptor-mediated insulin resistance, through conversion to more insulin resistant fast twitch fibers and through alpha-adrenergic vasoconstriction which may decrease the delivery of insulin and glucose to the skeletal muscle cells. The insulin resistance in turn may be responsible for the observed dyslipidemia in hypertension. The sympathetic overactivity in hypertension reflects a chronic activation of defense/vigilance reaction. The increase of cardiac output, blood pressure and insulin resistance in the course of the defense reaction are viewed as an appropriate preparatory response to facilitate muscular exercise (through higher cardiac output and increased pressure) and preserve (through insulin resistance) the optimal supply of glucose to the brain. The defense reaction may have been useful in evolution and may have offered survival advantage. In modern times with prolonged life expectancy the previously useful response (in evolutionary terms) contributes to a faster and deleterious wear and tear of the cardiovascular system.

Entities:  

Mesh:

Year:  1995        PMID: 7735282     DOI: 10.3109/10641969509087078

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  9 in total

Review 1.  Gene-environment interactions in hypertension.

Authors:  Z Pausova; J Tremblay; P Hamet
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

Review 2.  Epidemiology of risk factors for hypertension: implications for prevention and therapy.

Authors:  M Kornitzer; M Dramaix; G De Backer
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

Review 3.  The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.

Authors:  P Ernsberger; J E Friedman; R J Koletsky
Journal:  J Hypertens Suppl       Date:  1997-01

Review 4.  Metabolic effects of antihypertensive agents: role of sympathoadrenal and renin-angiotensin systems.

Authors:  Paul Ernsberger; Richard J Koletsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-17       Impact factor: 3.000

5.  Trajectories of maternal depressive symptoms over her child's life span: relation to adrenocortical, cardiovascular, and emotional functioning in children.

Authors:  Brooks B Gump; Jacki Reihman; Paul Stewart; Ed Lonky; Tom Darvill; Douglas A Granger; Karen A Matthews
Journal:  Dev Psychopathol       Date:  2009

6.  Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent.

Authors:  P Ernsberger; R J Koletsky; L A Collins; D Bedol
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

7.  Polymorphisms of the Flavin containing monooxygenase 3 (FMO3) gene do not predispose to essential hypertension in Caucasians.

Authors:  Ciara Dolan; Denis C Shields; Alice Stanton; Eoin O'Brien; Deborah M Lambert; John K O'Brien; Eileen P Treacy
Journal:  BMC Med Genet       Date:  2005-12-02       Impact factor: 2.103

8.  Ever at the ready for events that never happen.

Authors:  Jos F Brosschot
Journal:  Eur J Psychotraumatol       Date:  2017-04-10

Review 9.  Generalized Unsafety Theory of Stress: Unsafe Environments and Conditions, and the Default Stress Response.

Authors:  Jos F Brosschot; Bart Verkuil; Julian F Thayer
Journal:  Int J Environ Res Public Health       Date:  2018-03-07       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.